Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Punjab Chemicals & Crop Protection Ltd

PUNJABCHEM
NSE
1,131.65
3.08%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Punjab Chemicals & Crop Protection Ltd

PUNJABCHEM
NSE
1,131.65
3.08%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,388Cr
Close
Close Price
1,131.65
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
23.11
PS
Price To Sales
1.36
Revenue
Revenue
1,024Cr
Rev Gr TTM
Revenue Growth TTM
14.39%
PAT Gr TTM
PAT Growth TTM
75.07%
Peer Comparison
How does PUNJABCHEM stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
PUNJABCHEM
VS

Quarterly Results

Upcoming Results on
1 May 2026
Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
195281242214197242242214202320255247
Growth YoY
Revenue Growth YoY%
-24.63.4-13.1-17.80.8-13.90.0-0.12.931.95.415.3
Expenses
ExpensesCr
174244207188183215217195177285229217
Operating Profit
Operating ProfitCr
213835261328261926342630
OPM
OPM%
10.813.414.612.26.711.410.69.012.610.810.312.0
Other Income
Other IncomeCr
10211120-4460
Interest Expense
Interest ExpenseCr
747744545444
Depreciation
DepreciationCr
556566677777
PBT
PBTCr
1029251541817810282219
Tax
TaxCr
787415423735
PAT
PATCr
32218112131267211914
Growth YoY
PAT Growth YoY%
-83.57.93.1-44.2-24.7-38.5-31.7-45.8192.553.549.9127.5
NPM
NPM%
1.67.87.55.21.25.55.12.83.56.57.35.6
EPS
EPS
2.617.814.88.22.011.010.15.05.816.815.111.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
5655385254936435506789331,0069349011,024
Growth
Revenue Growth%
-4.8-2.5-6.030.4-14.523.437.67.8-7.2-3.613.7
Expenses
ExpensesCr
518497510452577507583794884821801908
Operating Profit
Operating ProfitCr
4741154266429614012311399116
OPM
OPM%
8.47.62.88.410.37.714.115.012.212.111.011.3
Other Income
Other IncomeCr
21401314-2132133-36
Interest Expense
Interest ExpenseCr
355031181718131218211817
Depreciation
DepreciationCr
191716141915151719222526
PBT
PBTCr
1414-192429226911289735479
Tax
TaxCr
11171211202828201518
PAT
PATCr
1413-20171711498361543960
Growth
PAT Growth%
-4.0-250.1186.2-2.2-36.0356.670.0-26.8-12.3-27.354.2
NPM
NPM%
2.52.5-3.83.52.62.07.28.96.15.74.35.9
EPS
EPS
11.610.8-16.014.013.78.840.068.149.843.731.849.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
121212121212121212121212
Reserves
ReservesCr
-474946627985132213268318352388
Current Liabilities
Current LiabilitiesCr
328231296214243227213250245237345223
Non Current Liabilities
Non Current LiabilitiesCr
18816584683769938291739170
Total Liabilities
Total LiabilitiesCr
482457439356371394451557616640801693
Current Assets
Current AssetsCr
206183180158171196233323362377522403
Non Current Assets
Non Current AssetsCr
277275259198200198218235254262279289
Total Assets
Total AssetsCr
482457439356371394451557616640801693

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
57105626168344534583025
Investing Cash Flow
Investing Cash FlowCr
1011-8-15-21-14-8-27-36-36-30
Financing Cash Flow
Financing Cash FlowCr
-72-141-61-43-4-19-26-11-20412
Net Cash Flow
Net Cash FlowCr
-14-8-7444211-42-27
Free Cash Flow
Free Cash FlowCr
54114484142917222-1-8
CFO To PAT
CFO To PAT%
415.0788.0-313.4357.4407.4320.690.741.195.355.864.8
CFO To EBITDA
CFO To EBITDA%
121.2257.2419.0147.5103.081.246.624.647.526.425.4

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2251703424778483701,0731,7861,0151,2051,139
Price To Earnings
Price To Earnings
15.912.80.027.850.534.421.921.416.622.529.3
Price To Sales
Price To Sales
0.40.30.71.01.30.71.61.91.01.31.3
Price To Book
Price To Book
-6.522.25.96.49.33.87.47.93.63.63.1
EV To EBITDA
EV To EBITDA
9.77.930.613.814.110.711.913.48.911.613.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
48.650.247.440.337.940.840.339.036.838.740.3
OPM
OPM%
8.47.62.88.410.37.714.115.012.212.111.0
NPM
NPM%
2.52.5-3.83.52.62.07.28.96.15.74.3
ROCE
ROCE%
23.229.26.523.925.421.637.638.928.520.713.4
ROE
ROE%
-40.021.7-34.123.218.511.034.037.021.816.210.7
ROA
ROA%
2.92.9-4.54.84.52.710.915.09.98.44.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Punjab Chemicals & Crop Protection Ltd. (PCCPL), established in 1975 as *Punjab United Pesticides & Chemicals Limited* through a joint venture with Excel Industries and PSIDC, has evolved into a leading Indian manufacturer in agrochemicals, specialty chemicals, and industrial chemicals. Listed on Indian stock exchanges since 1978, the company has leveraged over five decades of expertise in complex chemistry to transition into a knowledge-driven Contract Research and Manufacturing Services (CRAMS) provider, serving domestic and global innovator clients. Headquartered in India with three state-of-the-art manufacturing facilities in **Derabassi and Lalru (Punjab)** and **Pune (Maharashtra)**, PCCPL operates across multiple high-growth chemical segments, supporting a diversified international clientele. With total reactor capacity of 2000 KL and an installed production base of ~23,500 MTPA across 49.21 acres, the company is strategically expanding its footprint to capitalize on global supply chain shifts and emerging market opportunities. --- ### **Business Segments & Portfolio** PCCPL operates through **four core divisions**, each backed by dedicated R&D, manufacturing, and technical infrastructure: 1. **Agrochemicals/Intermediates** - Key products: Herbicides, fungicides, insecticides, patented and in-house developed molecules (e.g., Metamitron, Metconazole, Diflufenican). - Focus: Niche, multi-step complex chemistry for MNCs and mid-sized agro firms. - Over 60% of revenue contribution, with growing export orientation. 2. **Specialty & Performance Chemicals** - Includes high-value intermediates, active pharmaceutical ingredients (APIs), and fine chemicals. - Products from in-house R&D and CRAMS contracts. - Strategic growth area with rising revenue share from non-agro sectors. 3. **Pharmaceuticals** - Entry via acquisition of **Alpha Drug India Limited (2003)**. - Manufactures niche APIs and intermediates (e.g., Albendazole, Etoricoxib, Aminoacetonitrile) under cGMP standards. - CRAMS focus with exclusivity and long-term client partnerships. 4. **Industrial Chemicals** - Pune facility: Sole Indian producer of food-grade phosphoric acid via thermal process. - Offers phosphates, P₂O₅, customized oxalates, and gallic acid derivatives. - Supplies to beverage and pharmaceutical industries with FSSC 22000 and FSSAI certifications. --- ### **CRAMS Strategic Shift & Business Model** Since a deliberate pivot in **2016**, and further accelerated from **2022**, PCCPL has repositioned itself as a **preferred CRAMS (Contract Research and Manufacturing Services)** partner globally. The CRAMS segment now contributes over **65% of total revenue** and has emerged as the primary growth engine. - **Business Models Offered**: - End-to-end development: R&D → Commercial Production. - Technology transfer + Contract Manufacturing. - Joint CAPEX partnerships with exclusive, long-term contracts. - **Value Proposition**: - Fast turnaround, quality, safety, IP protection. - Cost-competitive manufacturing through process efficiency and backward integration. - Client-funded capital expansions, reducing financial risk. - **Target Clients**: - Global agrochemical MNCs (e.g., **Bayer, Nippon Kayaku, Nissan Chemical, Kureha**). - Domestic leaders (**Lupin, Laurus Labs, Zydus Cadila**). - Specialty chemical innovators seeking alternatives to Chinese suppliers. --- ### **Core Strengths & Capabilities** - **Technical Expertise**: Mastery in over **20 advanced chemical processes**, including: - Chlorination, bromination, nitration, photochlorination. - Cryogenic and high-pressure reactions. - Heterocyclic synthesis, hydrazine, benzylation, oxidation, azotisation. - Phosphorus-based and halogenation chemistry. - **R&D & Innovation**: - Two **dedicated R&D centers** (Derabassi & Lalru) with kilo labs and pilot plants. - Team of **30+ scientists**, including PhDs; expected to double by FY26. - Pipeline of **25+ products**, with ~8 in active development. - 40% of new business inquiries from **non-agrochemical sectors**, signaling diversification success. - **Manufacturing Excellence**: - Integrated, efficient, and scalable processes. - ISO 9001:2015, ISO 14001:2015 (environmental), FSSC 22000 (food safety) certified. - **Surplus capacity** across sites; current utilization at Derabassi (~81–85%), Lalru (~58%), Pune (>95%). - **Low-Cost Producer**: Achieved through backward integration, lean processes, and engineering efficiency, enhancing export competitiveness. --- ### **Financial & Operational Highlights (Recent Years)** - **FY2023**: Achieved record turnover of **₹1,000 crores (INR 10 billion / USD 120 million)**. - **FY2022**: Revenue of **₹933 crores**, EBITDA of **₹140 crores**, PAT of **₹84 crores**. - **FY2021**: Highest EBITDA in a decade at **₹97.3 crores**, driven by higher-margin CRAMS orders. - **CAGR (4 years)**: Revenue **~17.1%**, PAT **~48.4%**. - **Debt-to-Equity**: Improved from **1.4x (FY2018)** to **<0.4x (FY2023)** – strong financial health. --- ### **Key Partnerships & Market Positioning** - **Strategic MOUs**: Signed **three exclusive agreements** with overseas clients for high-value agrochemicals in Japanese and European markets. - **Global Clientele**: Includes **Bayer, Zydus, Laurus Labs, Lupin, Nippon Kayaku, Kureha, Nissan Chemical**, and others. - **Trusted CRAMS Partner**: Known for **reliability, scalability, and technical agility**, with consistent order renewal and long-term client stickiness.